Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid

British Journal of Cancer

Volumn 83, Issue 4, 2000, Pages 539-543

  Hinnen, P ^a   De Rooij, F W M ^a   Terlouw, E M ^a   Edixhoven, A ^a   Van Dekken, H ^a   Van Hillegersberg, R ^a   Tilanus, H W ^a   Wilson, J H P ^a   Siersema, P D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

5 Aminolaevulinic acid; Barrett's oesophagus; Photodynamic therapy; Porphyrin biosynthesis

Indexed keywords

AMINOLEVULINIC ACID; FERROCHELATASE; PORPHOBILINOGEN; PORPHOBILINOGEN DEAMINASE; PORPHYRIN; PROTOPORPHYRIN; UROPORPHYRIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BIOSYNTHESIS; BLOOD LEVEL; CARDIA; CASE REPORT; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HEME SYNTHESIS; HUMAN; HUMAN TISSUE; HYPOTENSION; INGESTION; LIVER FUNCTION; MALE; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; SIDE EFFECT; SQUAMOUS EPITHELIUM; VOMITING;

EID: 0033932641     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1300     Document Type: Article

References (23)

1. Barr H, Shepherd NA, Dix A, Roberts DJ, Tan WC and Krasner N (1996) Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 348: 584-585
2. Bishop DF and Desnick RJ (1981) Assays of the heme biosynthetic enzymes. Preface. Enzyme 28: 91-93
3. Cameron AJ and Carpenter HA (1997) Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 92: 586-591
4. Clark GW, Ireland AP and DeMeester TR (1996). Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. Dig Dis 14: 213-227
5. Drewitz DJ, Sampliner RE and Garewal HS (1997) The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92: 212-215
6. Edwards MJ, Gable DR, Lentsch AB and Richardson JD (1996) The rationale for esophagectomy as the optimal therapy fur Barrett's esophagus with high-grade dysplasia. Ann Surg 223: 585-589
7. Goldberg A and McGillion FB (1973) Proceedings: central uptake and cardiovascular effects of della-aminolaevulinic acid. Br J Pharmacol 49: 178P
8. Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn EG and Ell C (1998) Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 114: 448-455
9. Haggitt RC (1994) Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 25: 982-993
10. Hameefeman W, Tytgat GN, Houthoff HJ and van den Tweel JG (1989) Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96: 1249-1256
11. Henderson BW and Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55: 145-157
12. Herman MA, Webber J, Fromm D and Kessel D (1998) Hemodynamic effects of 5-aminolevulinic acid in humans. J Photochem Photobiol B 43: 61-65
13. Hinnen P, de Rooij FWM, Velthuysen van MLF, Edixhoven A, Hillegersberg van R, Tilanus HW, Wilson JHP and Siersema PD (1998) Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the esophagus. Br J Cancer 78: 679-682
14. Hinnen P, de Rooij FWM, Voortman G, Tilanus HW, Wilson JHP and Siersema PD (2000a) Acrylate yellow filters in operating lights protect against photosensitization tissue damage. Br J Surg 87: 231-235
15. Hinnen P, Siersema PD, Edixhoven A, Wilson JHP and de Rooij FWM (2000b) Ferrochelatase activity inhibition by 5-aminolaevulinic acid-induced photodynamic therapy, submitted for publication
16. inuma S, Farshi SS, Ortel B and Hasan T (1994) A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br J Cancer 70: 21-28
17. Kennedy JC and Pottier RH (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14: 275-292
18. Li G, Szewezuk MR, Pottier RH and Kennedy JC (1999) Effect of mammalian cell differentiation on response to exogenous 5-aminolevulinic acid. Photochem Photobiol 69: 231-235
19. Lowry O, Rosebrough N, Farr A and Randall R (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
20. Regula J, MacRobert AJ, Gorchein A, Buonaccorsi GA, Thorpe SM, Spencer GM, Hatfield AR and Bown SG (1995) Photosensitisation and photodynamic therapy of oesuphageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX - a pilot study. Gut 36: 67-75
21. van den Boogert J, van Hillegersberg R, de Rooij FW, de Bruin RW, Edixhoven-Bosdijk A, Houtsmuller AB, Siersema PD, Wilson JH and Tilanus HW (1998) 5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B 44: 29-38
22. van der Burgh A, Dees J, Hop WC and van Blankenstein M (1996) Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 39: 5-8
23. van Hillegersberg R, van den Berg JW, Kort WJ, Terpstra OT and Wilson JH (1992) Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology 103: 647-651